Rentokil Initial: Trian's Investment Adds To Growth Initiative (Rating Upgrade)

Focus North America However, a bigger share of the market is a double-edged sword, which can either upgrade a company's growth or drag it down. And right now, Rentokil Initial is at the wrong edge, with revenue growth of 3% in 2023 for the market, lower than the target rate of 3.5%. The number slowed down even more to 1.5% in the first quarter (Q1 2024). To fully contexualise why the North American revenue growth is a problem, consider two facts: For the full year 2023 and for Q1 2024, Rentokil Initial's ov ...